ArticleClinical, cosmetic and investigational dermatology2026
Case Report: Hereditary Angioedema Accompanied by Chronic Spontaneous Urticaria.
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chronic Spontaneous Urticaria with Biochemical C1 Inhibitor Deficiency: A Case Report of Suspected Overlap with Hereditary Angioedema.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent edema of the skin and tissues. Chronic spontaneous urticaria (CSU) is recurrent urticaria that lasts for more than 6 weeks without an apparent cause. It has long been believed that HAE does not occur with CSU. Patient and Case Description: Herein, we report a case of definite HAE with CSU. The patient was diagnosed with CSU due to recurrent clinical symptoms. After treatment with omalizumab, the symptoms of CSU improved, but there were still unpredictable recurrent episodes of edema. For further diagnosis, genetic testing and other laboratory examinations were performed, and it was confirmed that the patient also had HAE. Results: After treatment with omalizumab, the pruritus and erythema improved, confirming the diagnosis of CSU. The diagnosis of HAE (C1-INH deficiency, type 1) was established by WES, C1-INH concentration (0.08 g/L) and C4 level (25 mg/L) measurements, which explained the recurrent edema. Conclusion: We report a case with both HAE and CSU, suggesting that doctors should consider the possibility of co-existence of diseases in diagnosis, and attention should be paid to the timing of different treatment options such as omalizumab in the course of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.